RNA is a Structural Element in Retrovirus Particles

A single retroviral protein, Gag, is sufficient for virus particle assembly. While Gag is capable of specifically packaging the genomic RNA into the particle, this RNA species is unnecessary for particle assembly in vivo. In vitro, nucleic acids profoundly enhance the efficiency of assembly by recom...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 98; no. 9; pp. 5246 - 5251
Main Authors Muriaux, Delphine, Mirro, Jane, Harvin, Demetria, Rein, Alan
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 24.04.2001
National Acad Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A single retroviral protein, Gag, is sufficient for virus particle assembly. While Gag is capable of specifically packaging the genomic RNA into the particle, this RNA species is unnecessary for particle assembly in vivo. In vitro, nucleic acids profoundly enhance the efficiency of assembly by recombinant Gag proteins, apparently by acting as "scaffolding" in the particle. To address the participation of RNA in retrovirus assembly in vivo, we analyzed murine leukemia virus particles that lack genomic RNA because of a deletion in the packaging signal of the viral RNA. We found that these particles contain cellular mRNA in place of genomic RNA. This result was particularly evident when Gag was expressed by using a Semliki Forest virus-derived vector: under these conditions, the Semliki Forest virus vector-directed mRNA became very abundant in the cells and was readily identified in the retroviral virus-like particles. Furthermore, we found that the retroviral cores were disrupted by treatment with RNase. Taken together, the data strongly suggest that RNA is a structural element in retrovirus particles.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
To whom reprint requests should be addressed at: HIV Drug Resistance Program, National Cancer Institute–Frederick Cancer Research and Development Center, P.O. Box B, Frederick, MD 21702-1201. E-mail: rein@ncifcrf.gov.
Edited by John M. Coffin, Tufts University School of Medicine, Boston, MA, and approved February 23, 2001
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.091000398